Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 65OTHER_GOV 2UNKNOWN 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Pathologic Complete Response 1Breast Neoplasms 1

Interventions

palbociclib 2Fulvestrant 2pembrolizumab 1niraparib 1exemestane 1Therapeutics 1Standard of Care 1Radiotherapy, Adjuvant 1Radiation 1Pharmaceutical Preparations 1Neoadjuvant Therapy 1Methods 1Letrozole 1Immunotherapy 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Observational × Neoadjuvant Therapy × Clear all
NCT05441098 2022-07-01

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

ChineseAMS

Unknown
1,821 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡